JP2010526531A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010526531A5 JP2010526531A5 JP2010507438A JP2010507438A JP2010526531A5 JP 2010526531 A5 JP2010526531 A5 JP 2010526531A5 JP 2010507438 A JP2010507438 A JP 2010507438A JP 2010507438 A JP2010507438 A JP 2010507438A JP 2010526531 A5 JP2010526531 A5 JP 2010526531A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92799307P | 2007-05-07 | 2007-05-07 | |
| US60/927,993 | 2007-05-07 | ||
| PCT/US2008/005824 WO2008137163A1 (en) | 2007-05-07 | 2008-05-07 | Two-component genome flavivirus and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010526531A JP2010526531A (ja) | 2010-08-05 |
| JP2010526531A5 true JP2010526531A5 (ja) | 2010-12-02 |
| JP5537419B2 JP5537419B2 (ja) | 2014-07-02 |
Family
ID=39943863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010507438A Expired - Fee Related JP5537419B2 (ja) | 2007-05-07 | 2008-05-07 | 二成分ゲノムフラビウイルスおよびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8394620B2 (ja) |
| EP (1) | EP2150614B1 (ja) |
| JP (1) | JP5537419B2 (ja) |
| KR (1) | KR20100016313A (ja) |
| CN (1) | CN101802179A (ja) |
| AU (1) | AU2008248061B2 (ja) |
| BR (1) | BRPI0811281A2 (ja) |
| CA (1) | CA2686398C (ja) |
| IL (1) | IL201875A (ja) |
| RU (1) | RU2527891C2 (ja) |
| WO (1) | WO2008137163A1 (ja) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8815564B2 (en) | 2008-03-14 | 2014-08-26 | Sanofi Pasteur Biologics, Llc | Replication-defective flavivirus vaccines and vaccine vectors |
| CA2755257A1 (en) * | 2009-03-16 | 2010-09-23 | Sanofi Pasteur Biologics Co. | Replication-defective flavivirus vaccine vectors against respiratory syncytial virus |
| EP2435572B1 (en) | 2009-05-28 | 2017-08-16 | The United States of America, as Represented by The Secretary, Department of Health and Human Services | Antigenic chimeric tick-borne encephalitis virus (tbev)/dengue virus type 4 (den4) recombinant viruses |
| US8691961B1 (en) * | 2009-11-09 | 2014-04-08 | Integral Molecular, Inc. | Flavivirus reporter virus and methods of making and using the same |
| WO2013138776A1 (en) | 2012-03-16 | 2013-09-19 | Merial Limited | Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g |
| GB201716222D0 (en) * | 2017-10-05 | 2017-11-22 | Univ Leuven Kath | Chimeric Flavivirus Vaccines |
| CN113355292B (zh) * | 2021-06-04 | 2024-02-06 | 天康制药股份有限公司 | 一种猪圆环病毒基因改造型弱毒株、构建方法及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6676936B1 (en) | 1988-07-14 | 2004-01-13 | The United States Of America As Represented By The Department Of Health And Human Services. | Chimeric and/or growth-restricted flaviviruses |
| ATE314476T1 (de) | 1997-10-08 | 2006-01-15 | Us Gov Health & Human Serv | Chimärer impfstoff gegen das zeckenenzephalitis virus |
| US6541011B2 (en) | 1998-02-11 | 2003-04-01 | Maxygen, Inc. | Antigen library immunization |
| RU2288266C2 (ru) * | 2000-02-10 | 2006-11-27 | Зе Гавернмент Оф Зе Юнайтед Стэйтс Оф Америка, Эз Репрезентед Бай Зе Секретэри, Департмент Оф Хелс Энд Хьюмэн Сервисиз | ИНФЕКЦИОННЫЕ КЛОНЫ ПОЛНОМЕРНОЙ кДНК КЛЕЩЕВОГО ФЛАВИВИРУСА |
| ES2374131T3 (es) | 2000-02-16 | 2012-02-14 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Flavivirus quiméricos avirulentos e inmunógenos. |
| US7244434B2 (en) * | 2002-08-13 | 2007-07-17 | Intervet International B.V. | Replicons of pestviruses that do not express C and or E1 protein and infectious viral particles containing same, that can be used in vaccines |
| AU2003297860A1 (en) * | 2002-12-12 | 2004-07-09 | The Board Of Regents Of The University Of Texas System | Large scale production of packaged alphavirus replicons |
-
2008
- 2008-05-07 BR BRPI0811281-9A2A patent/BRPI0811281A2/pt not_active Application Discontinuation
- 2008-05-07 CN CN200880023471A patent/CN101802179A/zh active Pending
- 2008-05-07 EP EP08767607.8A patent/EP2150614B1/en active Active
- 2008-05-07 KR KR1020097023259A patent/KR20100016313A/ko active IP Right Grant
- 2008-05-07 RU RU2009145104/10A patent/RU2527891C2/ru not_active IP Right Cessation
- 2008-05-07 AU AU2008248061A patent/AU2008248061B2/en not_active Ceased
- 2008-05-07 WO PCT/US2008/005824 patent/WO2008137163A1/en active Application Filing
- 2008-05-07 CA CA2686398A patent/CA2686398C/en active Active
- 2008-05-07 US US12/151,491 patent/US8394620B2/en active Active
- 2008-05-07 JP JP2010507438A patent/JP5537419B2/ja not_active Expired - Fee Related
-
2009
- 2009-11-01 IL IL201875A patent/IL201875A/en not_active IP Right Cessation